{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:59:14Z","timestamp":1785139154474,"version":"3.55.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-026-10659-7","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:29:23Z","timestamp":1784860163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dyspnea in heart failure: pathophysiology, clinical assessment, and evidence from clinical trials"],"prefix":"10.1007","volume":"31","author":[{"given":"Mateusz","family":"Garus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Guzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Tymk\u00f3w","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Gajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zymli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Biegus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"10659_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"TA McDonagh","year":"2022","unstructured":"McDonagh TA, Metra M, Adamo M et al (2022) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 24:4\u2013131. https:\/\/doi.org\/10.1002\/ejhf.2333","journal-title":"Eur J Heart Fail"},{"key":"10659_CR2","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/eurjhf\/hft095","volume":"15","author":"F Zannad","year":"2013","unstructured":"Zannad F, Garcia AA, Anker SD et al (2013) Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail 15:1082\u20131094. https:\/\/doi.org\/10.1093\/eurjhf\/hft095","journal-title":"Eur J Heart Fail"},{"key":"10659_CR3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/ehf2.14688","volume":"11","author":"K Miger","year":"2024","unstructured":"Miger K, Overgaard Olesen AS, Grand J et al (2024) Computed tomography or chest X-ray to assess pulmonary congestion in dyspnoeic patients with acute heart failure. ESC Heart Fail 11:1163\u20131173. https:\/\/doi.org\/10.1002\/ehf2.14688","journal-title":"ESC Heart Fail"},{"key":"10659_CR4","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/ehf2.14969","volume":"11","author":"J Dauw","year":"2024","unstructured":"Dauw J, Sokolski M (2024) Do we need more tools or better tools to assess congestion? ESC Heart Fail 11:2481\u20132483. https:\/\/doi.org\/10.1002\/ehf2.14969","journal-title":"ESC Heart Fail"},{"key":"10659_CR5","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/ehf2.14690","volume":"11","author":"T Izumida","year":"2024","unstructured":"Izumida T, Imamura T, Koi T et al (2024) Prognostic impact of residual pulmonary congestion assessed by remote dielectric sensing system in patients admitted for heart failure. ESC Heart Fail 11:1443\u20131451. https:\/\/doi.org\/10.1002\/ehf2.14690","journal-title":"ESC Heart Fail"},{"key":"10659_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/ehf2.14982","volume":"12","author":"M Guazzi","year":"2025","unstructured":"Guazzi M, Novello G, Bursi F et al (2025) Biomarkers of lung congestion and injury in acute heart failure. ESC Heart Fail 12:781\u2013789. https:\/\/doi.org\/10.1002\/ehf2.14982","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10659_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1053\/euhj.2001.2803","volume":"23","author":"M Guazzi","year":"2002","unstructured":"Guazzi M, Pontone G, Brambilla R, Agostoni P, Reina G (2002) Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J 23(6):467\u2013476. https:\/\/doi.org\/10.1053\/euhj.2001.2803","journal-title":"Eur Heart J"},{"issue":"1","key":"10659_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1159\/000544929","volume":"15","author":"A Karimi","year":"2025","unstructured":"Karimi A, Mathew K, Pourafshar N (2025) Mechanisms of Congestion in Acute Decompensated Heart Failure. Cardiorenal Med 15(1):544\u2013551. https:\/\/doi.org\/10.1159\/000544929","journal-title":"Cardiorenal Med"},{"key":"10659_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/jcdd12040124","volume":"12","author":"D Mocan","year":"2025","unstructured":"Mocan D, Jipa R, Jipa DA, Lala RI, Rasinar FC, Groza I et al (2025) Unveiling the Systemic Impact of Congestion in Heart Failure: A Narrative Review of Multisystem Pathophysiology and Clinical Implications. J Cardiovasc Dev Dis 12:124. https:\/\/doi.org\/10.3390\/jcdd12040124","journal-title":"J Cardiovasc Dev Dis"},{"issue":"supplG","key":"10659_CR10","doi-asserted-by":"publisher","first-page":"G11","DOI":"10.1093\/eurheartj\/suw044","volume":"18","author":"M Arrigo","year":"2016","unstructured":"Arrigo M, Parissis JT, Akiyama E, Mebazaa A (2016) Understanding acute heart failure: pathophysiology and diagnosis. Eur Heart J Suppl 18(supplG):G11\u2013G18. https:\/\/doi.org\/10.1093\/eurheartj\/suw044","journal-title":"Eur Heart J Suppl"},{"key":"10659_CR11","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jchf.2023.05.034","volume":"11","author":"J Biegus","year":"2023","unstructured":"Biegus J, Borlaug BA, Testani JM (2023) Congestion and Decongestion Assessment in Heart Failure: Pressure, Volume, or Both? JACC Heart Fail 11:1152\u20131156. https:\/\/doi.org\/10.1016\/j.jchf.2023.05.034","journal-title":"JACC Heart Fail"},{"key":"10659_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijcard.2018.01.067","volume":"258","author":"J Rubio-Gracia","year":"2018","unstructured":"Rubio-Gracia J, Demissei BG, Ter Maaten JM et al (2018) Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol 258:185\u2013191. https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.067","journal-title":"Int J Cardiol"},{"issue":"1","key":"10659_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ahj.2006.02.038","volume":"155","author":"G Cotter","year":"2008","unstructured":"Cotter G, Felker GM, Adams KF, Milo-Cotter O, O\u2019Connor CM (2008) The pathophysiology of acute heart failure\u2013is it all about fluid accumulation? Am Heart J 155(1):9\u201318. https:\/\/doi.org\/10.1016\/j.ahj.2006.02.038","journal-title":"Am Heart J"},{"key":"10659_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ejhf.2053","volume":"23","author":"J Biegus","year":"2021","unstructured":"Biegus J, Zymlinski R, Testani J et al (2021) Renal profiling based on estimated glomerular filtration rate and spot urine sodium identifies high-risk acute heart failure patients. Eur J Heart Fail 23:729\u2013739. https:\/\/doi.org\/10.1002\/ejhf.2053","journal-title":"Eur J Heart Fail"},{"key":"10659_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jacc.2014.11.025","volume":"65","author":"P Nijst","year":"2015","unstructured":"Nijst P, Verbrugge FH, Grieten L, Dupont M, Steels P, Tang WHW, Mullens W (2015) The pathophysiological role of interstitial sodium in heart failure. J Am Coll Cardiol 65:378\u2013388. https:\/\/doi.org\/10.1016\/j.jacc.2014.11.025","journal-title":"J Am Coll Cardiol"},{"key":"10659_CR16","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jacbts.2024.02.016","volume":"9","author":"B Ponikowska","year":"2024","unstructured":"Ponikowska B, Biegus J, Fudim M et al (2024) Lower extremity lymphatic flow\/drainage assessment by indocyanine green fluorescent lymphography in heart failure patients. JACC Basic Transl Sci 9:906\u2013917. https:\/\/doi.org\/10.1016\/j.jacbts.2024.02.016","journal-title":"JACC Basic Transl Sci"},{"key":"10659_CR17","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/ejhf.3655","volume":"27","author":"B Ponikowska","year":"2025","unstructured":"Ponikowska B, Zymlinski R, Fudim M et al (2025) Lower extremity lymphatic flow is associated with diuretic response in acute heart failure. Eur J Heart Fail 27:1136\u20131144. https:\/\/doi.org\/10.1002\/ejhf.3655","journal-title":"Eur J Heart Fail"},{"key":"10659_CR18","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ehf2.15192","volume":"12","author":"J Biegus","year":"2025","unstructured":"Biegus J, Lindenfeld J, Felker GM et al (2025) Design and rationale of the eLym System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA-HF). ESC Heart Fail 12:1719\u20131726. https:\/\/doi.org\/10.1002\/ehf2.15192","journal-title":"ESC Heart Fail"},{"key":"10659_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejheart.2008.01.007","volume":"10","author":"G Cotter","year":"2008","unstructured":"Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M (2008) Fluid overload in acute heart failure\u2013re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 10:165\u2013169. https:\/\/doi.org\/10.1016\/j.ejheart.2008.01.007","journal-title":"Eur J Heart Fail"},{"key":"10659_CR20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCULATIONAHA.107.690768","volume":"116","author":"SI Chaudhry","year":"2007","unstructured":"Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM (2007) Patterns of weight change preceding hospitalization for heart failure. Circulation 116:1549\u20131554. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.690768","journal-title":"Circulation"},{"key":"10659_CR21","first-page":"1678","volume":"42","author":"CV Greenway","year":"1983","unstructured":"Greenway CV (1983) Role of splanchnic venous system in overall cardiovascular homeostasis. Fed Proc 42:1678\u20131684","journal-title":"Fed Proc"},{"key":"10659_CR22","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1186\/s40001-025-03350-4","volume":"30","author":"IJ Ogieuhi","year":"2025","unstructured":"Ogieuhi IJ, Anthony CS, Ajekiigbe VO et al (2025) Greater Splanchnic Nerve Ablation in Heart Failure with Preserved Ejection Fraction: a Mini-Narrative Review of Emerging Evidence. Eur J Med Res 30:1087. https:\/\/doi.org\/10.1186\/s40001-025-03350-4","journal-title":"Eur J Med Res"},{"issue":"5","key":"10659_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004750","volume":"11","author":"AS Eisman","year":"2018","unstructured":"Eisman AS, Shah RV, Dhakal BP et al (2018) Pulmonary capillary wedge pressure patterns during exercise predict exercise capacity and incident heart failure. Circ Heart Fail 11(5):e004750. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004750","journal-title":"Circ Heart Fail"},{"key":"10659_CR24","doi-asserted-by":"publisher","unstructured":"Leahy M, Wakeham D, MacNamara J et al (2025) Heart-Lung Interactions in HFpEF: Dynamic Hyperinflation and Exercise PCWP. JACC Heart Fail 13(8). https:\/\/doi.org\/10.1016\/j.jchf.2025.102523","DOI":"10.1016\/j.jchf.2025.102523"},{"key":"10659_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63742-0","volume":"14","author":"S Urban","year":"2024","unstructured":"Urban S, Szyma\u0144ski O, Grzesiak M et al (2024) Effectiveness of remote pulmonary artery pressure estimating in heart failure: systematic review and meta-analysis. Sci Rep 14:12929. https:\/\/doi.org\/10.1038\/s41598-024-63742-0","journal-title":"Sci Rep"},{"key":"10659_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ehf2.14825","volume":"12","author":"A Bayes-Genis","year":"2025","unstructured":"Bayes-Genis A, Petrie MC, Moura B et al (2025) Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure. ESC Heart Fail 12:54\u201359. https:\/\/doi.org\/10.1002\/ehf2.14825","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10659_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.resp.2004.12.007","volume":"148","author":"J Yu","year":"2005","unstructured":"Yu J (2005) Airway mechanosensors. Respir Physiol Neurobiol 148(3):217\u2013243. https:\/\/doi.org\/10.1016\/j.resp.2004.12.007","journal-title":"Respir Physiol Neurobiol"},{"issue":"1","key":"10659_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.resp.2008.10.002","volume":"167","author":"K Ravi","year":"2009","unstructured":"Ravi K, Kappagoda T (2009) Rapidly adapting receptors in acute heart failure and their impact on dyspnea. Respir Physiol Neurobiol 167(1):107\u2013115. https:\/\/doi.org\/10.1016\/j.resp.2008.10.002","journal-title":"Respir Physiol Neurobiol"},{"key":"10659_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2020.103595","volume":"287","author":"J Yu","year":"2021","unstructured":"Yu J (2021) A historical perspective of pulmonary rapidly adapting receptors. Respir Physiol Neurobiol 287:103595. https:\/\/doi.org\/10.1016\/j.resp.2020.103595","journal-title":"Respir Physiol Neurobiol"},{"issue":"5","key":"10659_CR30","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1378\/chest.10-0534","volume":"138","author":"NK Burki","year":"2010","unstructured":"Burki NK, Lee LY (2010) Mechanisms of dyspnea. Chest 138(5):1196\u20131201. https:\/\/doi.org\/10.1378\/chest.10-0534","journal-title":"Chest"},{"issue":"4","key":"10659_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1164\/rccm.201111-2042ST","volume":"185","author":"MB Parshall","year":"2012","unstructured":"Parshall MB, Schwartzstein RM, Adams L et al (2012) An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 185(4):435\u2013452. https:\/\/doi.org\/10.1164\/rccm.201111-2042ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10659_CR32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1152\/physrev.00039.2019","volume":"101","author":"R Iturriaga","year":"2021","unstructured":"Iturriaga R, Alcayaga J, Chapleau MW, Somers VK (2021) Carotid body chemoreceptors: physiology, pathology, and implications for health and disease. Physiol Rev 101(3):1177\u20131235. https:\/\/doi.org\/10.1152\/physrev.00039.2019","journal-title":"Physiol Rev"},{"issue":"1","key":"10659_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1023\/A:1009846123893","volume":"5","author":"HD Schultz","year":"2000","unstructured":"Schultz HD, Sun SY (2000) Chemoreflex function in heart failure. Heart Fail Rev 5(1):45\u201356. https:\/\/doi.org\/10.1023\/A:1009846123893","journal-title":"Heart Fail Rev"},{"issue":"4","key":"10659_CR34","first-page":"126","volume":"1","author":"P Ponikowski","year":"2001","unstructured":"Ponikowski P, Banasiak W (2001) Chemosensitivity in chronic heart failure. Heart Fail Monit 1(4):126\u2013131","journal-title":"Heart Fail Monit"},{"issue":"6","key":"10659_CR35","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cardfail.2013.03.013","volume":"19","author":"P Niewinski","year":"2013","unstructured":"Niewinski P, Engelman ZJ, Fudim M et al (2013) Clinical predictors and hemodynamic consequences of elevated peripheral chemosensitivity in optimally treated men with chronic systolic heart failure. J Card Fail 19(6):408\u2013415. https:\/\/doi.org\/10.1016\/j.cardfail.2013.03.013","journal-title":"J Card Fail"},{"issue":"2","key":"10659_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11897-014-0188-6","volume":"11","author":"P Niewinski","year":"2014","unstructured":"Niewinski P (2014) Pathophysiology and potential clinical applications for testing of peripheral chemosensitivity in heart failure. Curr Heart Fail Rep 11(2):126\u2013133. https:\/\/doi.org\/10.1007\/s11897-014-0188-6","journal-title":"Curr Heart Fail Rep"},{"issue":"4","key":"10659_CR37","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11906-013-0368-x","volume":"15","author":"HD Schultz","year":"2013","unstructured":"Schultz HD, Marcus NJ, Del Rio R (2013) Role of the carotid body in the pathophysiology of heart failure. Curr Hypertens Rep 15(4):356\u2013362. https:\/\/doi.org\/10.1007\/s11906-013-0368-x","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"10659_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1113\/expphysiol.2014.079517","volume":"100","author":"HD Schultz","year":"2015","unstructured":"Schultz HD, Marcus NJ, Del Rio R (2015) Mechanisms of carotid body chemoreflex dysfunction during heart failure. Exp Physiol 100(2):124\u2013129. https:\/\/doi.org\/10.1113\/expphysiol.2014.079517","journal-title":"Exp Physiol"},{"key":"10659_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00438","volume":"5","author":"NJ Marcus","year":"2014","unstructured":"Marcus NJ, Del Rio R, Schultz HD (2014) Central role of carotid body chemoreceptors in disordered breathing and cardiorenal dysfunction in chronic heart failure. Front Physiol 5:438. https:\/\/doi.org\/10.3389\/fphys.2014.00438","journal-title":"Front Physiol"},{"key":"10659_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.878363","volume":"13","author":"K Kulej-Lyko","year":"2022","unstructured":"Kulej-Lyko K, Niewinski P, Tubek S, Ponikowski P (2022) Contribution of peripheral chemoreceptors to exercise intolerance in heart failure. Front Physiol 13:878363. https:\/\/doi.org\/10.3389\/fphys.2022.878363","journal-title":"Front Physiol"},{"key":"10659_CR41","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1002\/ehf2.15308","volume":"12","author":"H Jiang","year":"2025","unstructured":"Jiang H, Wattanachayakul P, Kittipibul V et al (2025) Pulmonary artery pressure trajectories in heart failure patients treated with GLP-1 receptor agonists. ESC Heart Fail 12:2578\u20132582. https:\/\/doi.org\/10.1002\/ehf2.15308","journal-title":"ESC Heart Fail"},{"key":"10659_CR42","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/ehf2.14641","volume":"11","author":"M Lembo","year":"2024","unstructured":"Lembo M, Strisciuglio T, Fonderico C et al (2024) Obesity: the perfect storm for heart failure. ESC Heart Fail 11:1841\u20131860. https:\/\/doi.org\/10.1002\/ehf2.14641","journal-title":"ESC Heart Fail"},{"key":"10659_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14134774","volume":"14","author":"LE Corneanu","year":"2025","unstructured":"Corneanu LE, S\u00eengeap MS, Mutruc V et al (2025) The complex relationship between heart failure and chronic obstructive pulmonary disease: a comprehensive review. J Clin Med 14:4774. https:\/\/doi.org\/10.3390\/jcm14134774","journal-title":"J Clin Med"},{"issue":"2","key":"10659_CR44","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/ehf2.15127","volume":"12","author":"PM Becher","year":"2025","unstructured":"Becher PM, Lindberg F, Benson L et al (2025) Phenotyping patients with chronic obstructive pulmonary disease and heart failure. ESC Heart Fail 12(2):900\u2013911. https:\/\/doi.org\/10.1002\/ehf2.15127","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10659_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11897-024-00660-2","volume":"21","author":"SHR Ramalho","year":"2024","unstructured":"Ramalho SHR, de Albuquerque ALP (2024) Chronic Obstructive Pulmonary Disease in Heart Failure: Challenges in Diagnosis and Treatment for HFpEF and HFrEF. Curr Heart Fail Rep 21(3):163\u2013173. https:\/\/doi.org\/10.1007\/s11897-024-00660-2","journal-title":"Curr Heart Fail Rep"},{"key":"10659_CR46","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1002\/ehf2.15373","volume":"12","author":"H Yaakoubi","year":"2025","unstructured":"Yaakoubi H, Boukadida L, Toumia M et al (2025) Intense Optimization of Oral Therapy Rapidly Restores Respiratory Function in Worsening Heart Failure Patients. ESC Heart Fail 12:3569\u20133578. https:\/\/doi.org\/10.1002\/ehf2.15373","journal-title":"ESC Heart Fail"},{"key":"10659_CR47","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/ehf2.14560","volume":"11","author":"G Cimino","year":"2024","unstructured":"Cimino G, Vaduganathan M, Lombardi CM et al (2024) Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists. ESC Heart Fail 11:649\u2013661. https:\/\/doi.org\/10.1002\/ehf2.14560","journal-title":"ESC Heart Fail"},{"key":"10659_CR48","doi-asserted-by":"publisher","unstructured":"Butler J, Shah SJ, Magwire M et al (2024) Treatment pathways in patients with heart failure with preserved ejection fraction and obesity. Glob Cardiol 2. https:\/\/doi.org\/10.4081\/cardio.2024.38","DOI":"10.4081\/cardio.2024.38"},{"key":"10659_CR49","doi-asserted-by":"publisher","unstructured":"Fioretti F, Lindman BR, Butler J (2024) Biological plausibility and implications of obesity associated valvular heart diseases. Glob Cardiol 2. https:\/\/doi.org\/10.4081\/cardio.2024.49","DOI":"10.4081\/cardio.2024.49"},{"key":"10659_CR50","doi-asserted-by":"publisher","unstructured":"Anker SD, Ji L, Kindel T et al (2025) iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025. Glob Cardiol 3. https:\/\/doi.org\/10.4081\/cardio.2025.86","DOI":"10.4081\/cardio.2025.86"},{"key":"10659_CR51","doi-asserted-by":"publisher","unstructured":"Waqas SA, Siddiqui H, Kallel F, Hassan S (2025) Is the obesity paradox present in left ventricular assist device recipients? Glob Cardiol 3. https:\/\/doi.org\/10.4081\/cardio.2025.84","DOI":"10.4081\/cardio.2025.84"},{"key":"10659_CR52","doi-asserted-by":"publisher","unstructured":"Zieroth S, Pinto F, Anker SD et al (2025) Applicability of obesity clinical practice guidelines in low- and middle-income countries. Glob Cardiol 3. https:\/\/doi.org\/10.4081\/cardio.2025.77","DOI":"10.4081\/cardio.2025.77"},{"issue":"2","key":"10659_CR53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.14797\/mdcvj.1511","volume":"21","author":"H Alansari","year":"2025","unstructured":"Alansari H, Lazzara G, Taha MB, Gorthi JR (2025) The impact of obesity on cardiovascular diseases: heart failure. Methodist Debakey Cardiovasc J 21(2):44\u201352. https:\/\/doi.org\/10.14797\/mdcvj.1511","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"1","key":"10659_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12933-025-02612-z","volume":"24","author":"BM van Dalen","year":"2025","unstructured":"van Dalen BM, Chin JF, Motiram PA et al (2025) Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity. Cardiovasc Diabetol 24(1):71. https:\/\/doi.org\/10.1186\/s12933-025-02612-z","journal-title":"Cardiovasc Diabetol"},{"key":"10659_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2025.05.013","author":"S Uchida","year":"2025","unstructured":"Uchida S, Kamiya K, Yamashita M, Noda T, Kagiyama N, Matsue Y (2025) Current findings and challenges on frailty, sarcopenia, and cachexia in older patients with heart failure. J Cardiol. https:\/\/doi.org\/10.1016\/j.jjcc.2025.05.013","journal-title":"J Cardiol"},{"issue":"1","key":"10659_CR56","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/ehf2.15044","volume":"12","author":"B Bai","year":"2025","unstructured":"Bai B, Li D, Xu M et al (2025) Clinical implication of sarcopenia in patients with acute decompensated heart failure. ESC Heart Fail 12(1):640\u2013648. https:\/\/doi.org\/10.1002\/ehf2.15044","journal-title":"ESC Heart Fail"},{"key":"10659_CR57","doi-asserted-by":"publisher","unstructured":"Anker SD, Shahzeb Khan M, Arshad Khan L et al (2024) The muscle hypothesis of shortness of breath in patients with cachexia. Glob Cardiol 2. https:\/\/doi.org\/10.4081\/cardio.2024.57","DOI":"10.4081\/cardio.2024.57"},{"key":"10659_CR58","doi-asserted-by":"publisher","unstructured":"Shahzeb Khan M, Butler J, Arshad Khan L, Anker MS (2024) Advanced cancer as a heart failure like syndrome due to cardiac wasting cardiomyopathy. Glob Cardiol 2. https:\/\/doi.org\/10.4081\/cardio.2024.58","DOI":"10.4081\/cardio.2024.58"},{"key":"10659_CR59","doi-asserted-by":"publisher","unstructured":"Hameed I, Nashit M, Quettawala Mufaddal Z, Javaid SS, Hanif M (2025) Demographic and regional trends of heart failure and cachexia-related mortality among older adults in the United States, 1999 to 2020. Glob Cardiol 3. https:\/\/doi.org\/10.4081\/cardio.2025.83","DOI":"10.4081\/cardio.2025.83"},{"key":"10659_CR60","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/ehf2.15170","volume":"12","author":"L Lanser","year":"2025","unstructured":"Lanser L, Polzl G, Messner M et al (2025) Prevalence of iron deficiency in acute and chronic heart failure according to different clinical definitions. ESC Heart Fail 12:1606\u20131619. https:\/\/doi.org\/10.1002\/ehf2.15170","journal-title":"ESC Heart Fail"},{"key":"10659_CR61","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/ehf2.15128","volume":"12","author":"S Verstreken","year":"2025","unstructured":"Verstreken S, Beles M, Oeste CL et al (2025) EGFR slope as predictor of mortality in heart failure patients. ESC Heart Fail 12:1217\u20131226. https:\/\/doi.org\/10.1002\/ehf2.15128","journal-title":"ESC Heart Fail"},{"key":"10659_CR62","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1002\/ehf2.14849","volume":"11","author":"CC Cabrera","year":"2024","unstructured":"Cabrera CC, Ekstrom M, Tornvall P et al (2024) Iron deficiency in new onset heart failure. ESC Heart Fail 11:2661\u20132671. https:\/\/doi.org\/10.1002\/ehf2.14849","journal-title":"ESC Heart Fail"},{"key":"10659_CR63","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/ehf2.14601","volume":"11","author":"A Sharma","year":"2024","unstructured":"Sharma A, Inzucchi SE, Testani JM et al (2024) Kidney and heart failure events are bidirectionally associated in patients with type 2 diabetes and cardiovascular disease. ESC Heart Fail 11:737\u2013747. https:\/\/doi.org\/10.1002\/ehf2.14601","journal-title":"ESC Heart Fail"},{"key":"10659_CR64","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/ehf2.14724","volume":"11","author":"S Sharma","year":"2024","unstructured":"Sharma S, Katz R, Chaves PHM et al (2024) Iron Deficiency and Incident Heart Failure in Older Community-Dwelling Individuals. ESC Heart Fail 11:1435\u20131442. https:\/\/doi.org\/10.1002\/ehf2.14724","journal-title":"ESC Heart Fail"},{"key":"10659_CR65","doi-asserted-by":"publisher","unstructured":"Akintunde AA, Orugun ST (2024) The association of iron deficiency with right ventricular dysfunction in Africans with heart failure. Glob Cardiol 2. https:\/\/doi.org\/10.4081\/cardio.2024.53","DOI":"10.4081\/cardio.2024.53"},{"key":"10659_CR66","doi-asserted-by":"publisher","unstructured":"Aland SC, Gertler C, Br\u00e4unig HL et al (2024) Exercise capacity, iron deficiency and depressive symptoms in patients with asymptomatic chronic systolic heart failure. Glob Cardiol 2. https:\/\/doi.org\/10.4081\/cardio.2024.39","DOI":"10.4081\/cardio.2024.39"},{"key":"10659_CR67","doi-asserted-by":"publisher","unstructured":"Khan LA, Javaid SS, Butler J (2025) Iron supplementation in heart failure and iron deficiency: does it help? Glob Cardiol 3. https:\/\/doi.org\/10.4081\/cardio.2025.82","DOI":"10.4081\/cardio.2025.82"},{"issue":"8","key":"10659_CR68","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1038\/s41591-025-03671-1","volume":"31","author":"SD Anker","year":"2025","unstructured":"Anker SD, Karakas M, Mentz RJ et al (2025) Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency. Nat Med 31(8):2640\u20132646. https:\/\/doi.org\/10.1038\/s41591-025-03671-1","journal-title":"Nat Med"},{"issue":"5","key":"10659_CR69","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/ejhf.3534","volume":"27","author":"N De Biase","year":"2025","unstructured":"De Biase N, Del Punta L, L\u2019Hoyes W et al (2025) Associations of iron deficiency with cardiac function, congestion, exercise capacity and prognosis in heart failure. Eur J Heart Fail 27(5):889\u2013900. https:\/\/doi.org\/10.1002\/ejhf.3534","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10659_CR70","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"W Paulus","year":"2013","unstructured":"Paulus W, Tsch\u00f6pe C (2013) A Novel Paradigm for Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol 62(4):263\u2013271. https:\/\/doi.org\/10.1016\/j.jacc.2013.02.092","journal-title":"J Am Coll Cardiol"},{"key":"10659_CR71","doi-asserted-by":"publisher","first-page":"963","DOI":"10.17219\/dmp\/210102","volume":"62","author":"MM Wilk","year":"2025","unstructured":"Wilk MM, Wilk J, Florek K, Zimoch WJ (2025) Smoldering inflammation: The silent flame driving heart failure. Dent Med Probl 62:963\u2013976. https:\/\/doi.org\/10.17219\/dmp\/210102","journal-title":"Dent Med Probl"},{"key":"10659_CR72","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1002\/ehf2.15277","volume":"12","author":"GHD Voordes","year":"2025","unstructured":"Voordes GHD, Voors AA, Qin H, Ter Maaten JM, Damman K (2025) Signs of congestion, quality of life and short-term rehospitalization in patients with heart failure. ESC Heart Fail 12:2477\u20132486. https:\/\/doi.org\/10.1002\/ehf2.15277","journal-title":"ESC Heart Fail"},{"issue":"11","key":"10659_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.101987","volume":"48","author":"S Rashid","year":"2023","unstructured":"Rashid S, Qureshi AG, Noor TA et al (2023) Anxiety and depression in heart failure: an updated review. Curr Probl Cardiol 48(11):101987. https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101987","journal-title":"Curr Probl Cardiol"},{"key":"10659_CR74","doi-asserted-by":"publisher","unstructured":"Sedlar Kobe N, Omersa D, Lainscak M, Farkas J (2024) Depression, health-related quality of life and life satisfaction in patients with heart failure. Glob Cardiol 2. https:\/\/doi.org\/10.4081\/cardio.2024.47","DOI":"10.4081\/cardio.2024.47"},{"key":"10659_CR75","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1002\/ehf2.14758","volume":"11","author":"A Sherwood","year":"2024","unstructured":"Sherwood A, Blumenthal JA, Mentz RJ et al (2024) Depressive symptoms are associated with clinical outcomes in heart failure with reduced ejection fraction. ESC Heart Fail 11:2627\u20132636. https:\/\/doi.org\/10.1002\/ehf2.14758","journal-title":"ESC Heart Fail"},{"key":"10659_CR76","doi-asserted-by":"publisher","first-page":"728772","DOI":"10.3389\/fmed.2021.728772","volume":"8","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhao C, Zhang H et al (2021) Dyspnea Measurement in Acute Heart Failure: A Systematic Review and Evidence Map of Randomized Controlled Trials. Front Med (Lausanne) 8:728772. https:\/\/doi.org\/10.3389\/fmed.2021.728772","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10659_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.54996\/anatolianjem.1053506","volume":"6","author":"C Kara Geno\u011flu","year":"2023","unstructured":"Kara Geno\u011flu C, K\u00f6se A, Bozkurt Babu\u015f S et al (2023) Assessment of Dyspnea in Acute Heart Failure Patients with Three Scales in the Emergency Department. Anatol J Emerg Med 6(1):1\u20136. https:\/\/doi.org\/10.54996\/anatolianjem.1053506","journal-title":"Anatol J Emerg Med"},{"issue":"3","key":"10659_CR78","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4037\/ajcc1998.7.3.200","volume":"7","author":"AG Gift","year":"1998","unstructured":"Gift AG, Narsavage G (1998) Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care 7(3):200\u2013204","journal-title":"Am J Crit Care"},{"key":"10659_CR79","doi-asserted-by":"publisher","unstructured":"Wysham NG, Miriovsky BJ, Currow DC, Herndon JE 2nd, Samsa GP, Wilcock A, Abernethy AP (2015) Practical dyspnea assessment: relationship between the 0\u201310 numerical rating scale and the four-level categorical verbal descriptor scale of dyspnea intensity. J Pain Symptom Manage 50(4):480\u2013487. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.04.015","DOI":"10.1016\/j.jpainsymman.2015.04.015"},{"issue":"6","key":"10659_CR80","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1159\/000095910","volume":"73","author":"A von Leupoldt","year":"2006","unstructured":"von Leupoldt A, Ambruzsova R, Nordmeyer S, Jeske N, Dahme B (2006) Sensory and affective aspects of dyspnea contribute differentially to the Borg scale\u2019s measurement of dyspnea. Respiration 73(6):762\u2013768. https:\/\/doi.org\/10.1159\/000095910","journal-title":"Respiration"},{"issue":"17","key":"10659_CR81","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1093\/eurjpc\/zwae291","volume":"31","author":"H Saito","year":"2024","unstructured":"Saito H, Maeda D, Kagiyama N et al (2024) Prognostic value of Borg scale following 6-min walk test in hospitalized older patients with heart failure. Eur J Prev Cardiol 31(17):2036\u20132043. https:\/\/doi.org\/10.1093\/eurjpc\/zwae291","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"10659_CR82","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/acem.12390","volume":"21","author":"PS Pang","year":"2014","unstructured":"Pang PS, Collins SP, Sauser K et al (2014) Assessment of dyspnea early in acute heart failure: patient characteristics and response differences between likert and visual analog scales. Acad Emerg Med 21(6):659\u2013666. https:\/\/doi.org\/10.1111\/acem.12390","journal-title":"Acad Emerg Med"},{"issue":"5","key":"10659_CR83","doi-asserted-by":"publisher","first-page":"341","DOI":"10.6061\/clinics\/2014(05)08","volume":"69","author":"CK Weber","year":"2014","unstructured":"Weber CK, Miglioranza MH, Moraes MA et al (2014) The five-point Likert scale for dyspnea can properly assess the degree of pulmonary congestion and predict adverse events in heart failure outpatients. Clin (Sao Paulo) 69(5):341\u2013346. https:\/\/doi.org\/10.6061\/clinics\/2014(05)08","journal-title":"Clin (Sao Paulo)"},{"issue":"3","key":"10659_CR84","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.amjcard.2019.05.011","volume":"124","author":"NS Hendren","year":"2019","unstructured":"Hendren NS, Drazner MH, Pandey A, Tang WHW, Grodin JL (2019) Implications of Perceived Dyspnea and Global Well-Being Measured by Visual Assessment Scales During Treatment for Acute Decompensated Heart Failure. Am J Cardiol 124(3):402\u2013408. https:\/\/doi.org\/10.1016\/j.amjcard.2019.05.011","journal-title":"Am J Cardiol"},{"issue":"2","key":"10659_CR85","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1001\/jamacardio.2022.4427","volume":"8","author":"LE Rohde","year":"2023","unstructured":"Rohde LE, Zimerman A, Vaduganathan M et al (2023) Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure. JAMA Cardiol 8(2):150\u2013158. https:\/\/doi.org\/10.1001\/jamacardio.2022.4427","journal-title":"JAMA Cardiol"},{"issue":"23","key":"10659_CR86","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014240","volume":"8","author":"C Caraballo","year":"2019","unstructured":"Caraballo C, Desai NR, Mulder H et al (2019) Clinical implications of the New York Heart Association classification. J Am Heart Assoc 8(23):e014240. https:\/\/doi.org\/10.1161\/JAHA.119.014240","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10659_CR87","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.resp.2008.07.012","volume":"167","author":"RW Lansing","year":"2009","unstructured":"Lansing RW, Gracely RH, Banzett RB (2009) The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 167(1):53\u201360. https:\/\/doi.org\/10.1016\/j.resp.2008.07.012","journal-title":"Respir Physiol Neurobiol"},{"issue":"6","key":"10659_CR88","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1183\/09031936.00038914","volume":"45","author":"RB Banzett","year":"2015","unstructured":"Banzett RB, O\u2019Donnell CR, Guilfoyle TE et al (2015) Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research. Eur Respir J 45(6):1681\u20131691. https:\/\/doi.org\/10.1183\/09031936.00038914","journal-title":"Eur Respir J"},{"issue":"1","key":"10659_CR89","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/thx.2009.118521","volume":"65","author":"J Yorke","year":"2010","unstructured":"Yorke J, Moosavi SH, Shuldham C, Jones PW (2010) Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 65(1):21\u201326. https:\/\/doi.org\/10.1136\/thx.2009.118521","journal-title":"Thorax"},{"issue":"1","key":"10659_CR90","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.jpainsymman.2021.06.023","volume":"63","author":"MT Williams","year":"2022","unstructured":"Williams MT, Lewthwaite H, Paquet C et al (2022) Dyspnoea-12 and Multidimensional Dyspnea Profile: Systematic Review of Use and Properties. J Pain Symptom Manage 63(1):e75\u2013e87. https:\/\/doi.org\/10.1016\/j.jpainsymman.2021.06.023","journal-title":"J Pain Symptom Manage"},{"key":"10659_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20525-9","volume":"12","author":"M Garus","year":"2022","unstructured":"Garus M, Zdanowicz A, Fudim M et al (2022) Clinical determinants and prognostic significance of hypocapnia in acute heart failure. Sci Rep 12:16889. https:\/\/doi.org\/10.1038\/s41598-022-20525-9","journal-title":"Sci Rep"},{"key":"10659_CR92","doi-asserted-by":"publisher","first-page":"e075302","DOI":"10.1136\/bmjopen-2023-075302","volume":"13","author":"M Garus","year":"2023","unstructured":"Garus M, Jura M, Guzik M et al (2023) Prognostic significance and clinical determinants of residual dyspnoea at discharge in acute heart failure. BMJ Open 13:e075302. https:\/\/doi.org\/10.1136\/bmjopen-2023-075302","journal-title":"BMJ Open"},{"issue":"12","key":"10659_CR93","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/jama.287.12.1531","volume":"287","author":"Publication Committee for the VMAC Investigators","year":"2002","unstructured":"Publication Committee for the VMAC Investigators (2002) Intravenous Nesiritide vs Nitroglycerin for Treatment of Decompensated Congestive Heart Failure. JAMA 287(12):1531\u20131540. https:\/\/doi.org\/10.1001\/jama.287.12.1531","journal-title":"JAMA"},{"issue":"8","key":"10659_CR94","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cardfail.2008.08.010","volume":"14","author":"G Cotter","year":"2008","unstructured":"Cotter G, Dittrich HC, Weatherley BD et al (2008) The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail 14(8):631\u2013640. https:\/\/doi.org\/10.1016\/j.cardfail.2008.08.010","journal-title":"J Card Fail"},{"issue":"15","key":"10659_CR95","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","volume":"363","author":"BM Massie","year":"2010","unstructured":"Massie BM, O\u2019Connor CM, Metra M et al (2010) Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 363(15):1419\u20131428. https:\/\/doi.org\/10.1056\/NEJMoa0912613","journal-title":"N Engl J Med"},{"issue":"1","key":"10659_CR96","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1100171","volume":"365","author":"CM O\u2019Connor","year":"2011","unstructured":"O\u2019Connor CM, Starling RC, Hernandez AF et al (2011) Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 365(1):32\u201343. https:\/\/doi.org\/10.1056\/NEJMoa1100171","journal-title":"N Engl J Med"},{"issue":"20","key":"10659_CR97","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1056\/NEJMoa1601895","volume":"376","author":"M Packer","year":"2017","unstructured":"Packer M, O\u2019Connor C, McMurray JJV et al (2017) Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure. N Engl J Med 376(20):1956\u20131964. https:\/\/doi.org\/10.1056\/NEJMoa1601895","journal-title":"N Engl J Med"},{"issue":"9860","key":"10659_CR98","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","volume":"381","author":"JR Teerlink","year":"2013","unstructured":"Teerlink JR, Cotter G, Davison BA et al (2013) Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF). Lancet 381(9860):29\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(12)61855-8","journal-title":"Lancet"},{"issue":"8","key":"10659_CR99","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1056\/NEJMoa1801291","volume":"381","author":"M Metra","year":"2019","unstructured":"Metra M, Teerlink JR, Cotter G et al (2019) Effects of Serelaxin in Patients With Acute Heart Failure. N Engl J Med 381(8):716\u2013726. https:\/\/doi.org\/10.1056\/NEJMoa1801291","journal-title":"N Engl J Med"},{"issue":"4","key":"10659_CR100","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/ejhf.1713","volume":"22","author":"K Damman","year":"2020","unstructured":"Damman K, Beusekamp JC, Boorsma EM et al (2020) Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF). Eur J Heart Fail 22(4):713\u2013722. https:\/\/doi.org\/10.1002\/ejhf.1713","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10659_CR101","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","volume":"28","author":"AA Voors","year":"2022","unstructured":"Voors AA, Angermann CE, Teerlink JR et al (2022) The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure. Nat Med 28(3):568\u2013574. https:\/\/doi.org\/10.1038\/s41591-021-01659-1","journal-title":"Nat Med"},{"key":"10659_CR102","doi-asserted-by":"publisher","first-page":"176179","DOI":"10.1016\/j.ejphar.2023.176179","volume":"961","author":"AN Emara","year":"2023","unstructured":"Emara AN, Wadie M, Mansour NO, Shams MEE (2023) The clinical outcomes of dapagliflozin in patients with acute heart failure (DAPA-RESPONSE-AHF). Eur J Pharmacol 961:176179. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176179","journal-title":"Eur J Pharmacol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10659-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10659-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10659-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:02:13Z","timestamp":1785135733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10659-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10659"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10659-7","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"88"}}